This content is restricted.
Brief
"On July 14, 2025, the Federal Trade Commission issued an update regarding FTC Takes Action Against Telemedicine Firm NextMed Over Charges It Used Misleading Prices, Fake Reviews, and Deceptive Weight Loss Claims to Sell GLP-1 Weight-Loss Programs. The Commission alleges that NextMed used deceptive cost and weight loss claims, fake reviews, and hidden terms in its membership programs to lure consumers into buying their weight-loss programs."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested